Oakland, CA, United States of America

Zachary Boyd

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Zachary Boyd

Introduction

Zachary Boyd is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic applications. With a total of two patents to his name, Boyd's work is paving the way for advancements in medical science.

Latest Patents

Zachary Boyd's latest patents include "Anti-PD-L1 antibodies and diagnostic uses thereof." This invention provides programmed death-ligand 1 (PD-L1) antibodies and methods for utilizing them in various medical applications. His innovative approach aims to enhance the effectiveness of cancer treatments by targeting specific pathways involved in tumor growth.

Career Highlights

Throughout his career, Boyd has worked with notable companies such as Ventana Medical Systems, Inc. and Spring Bioscience Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of immunotherapy.

Collaborations

Zachary Boyd has collaborated with esteemed colleagues, including Marcin Kowanetz and Hartmut Koeppen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Zachary Boyd's contributions to the field of biotechnology through his innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future developments in cancer treatment and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…